Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07022496

Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals

Assessment of Oral Caffeine Intake in Reducing the Severity of Acute Migraine Attack Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals: A Randomized Controlled Trial

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Caffeine extracted from green tea to abort acute attack of Migraine

Detailed description

Caffeine tablets extracted from green tea can be used as caffeinated drinks to decrease intensity of migraine attacks

Conditions

Interventions

TypeNameDescription
DRUGCaffeine (200 mg)caffeine tablets
DRUGtriptansSumatriptan
DRUGNSAID (Nonsteroidal anti-inflammatory drugs)Aspirin 250 mg, 81 mg, 75 mg
DRUGParacetamol (acetaminophen)Paracetamol 250 mg

Timeline

Start date
2023-04-26
Primary completion
2025-07-01
Completion
2025-08-01
First posted
2025-06-15
Last updated
2025-06-15

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07022496. Inclusion in this directory is not an endorsement.